Drugging the Elusive KRAS
Kevan M. Shokat, PhD, shifted the paradigm of targeted cancer therapy by drugging an “undruggable” protein and paving the way for future advances.
Cancer Talk
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
Progress in Lung CancerNovember is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
Against All OddsAt age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren
From the AACR
-
Chemtai Mungo, MD, MPH: Bringing Cervical Cancer Treatment to More Women
An innovative self-treatment strategy for cervical precancer could save lives in low- and middle-income countries as well as underserved areas in the U.S.
-
From the Bench: Creative Approaches in Cancer Research
Insects that smell cancer, new CRISPR delivery tools, and a cancer-fighting battery—the AACR's new blog series, From the Bench, highlights creative approaches in cancer research.
Video
Ricki Fairley: Surviving and Thriving After Triple Negative Breast Cancer
